Association of Interleukin-18 gene promoter polymorphisms with breast cancer

Neoplasma

Volumn 56, Issue 1, 2009, Pages 22-25

  Khalili Azad, T ^a   Razmkhah, M ^b   Ghiam, A F ^b   Doroudchi, M ^b   Talei, A R ^a   Mojtahedi, Z ^b   Ghaderi, A ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; IL 18; Polymorphism

Indexed keywords

INTERLEUKIN 18;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER INCIDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-18; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 66549111152     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_01_22     Document Type: Article

References (21)

1. Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. J Immunol 2001; 167: 1644-1653
2. Nakanishi K, Yoshimoto T, Tsutsui H et al. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53-72. doi:10.1016/S1359-6101(00) 00015-0 (Pubitemid 32294587)
3. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004; 11: 405-410 doi:10.1097/01.moh.0000141926.95319.42 PMid:15548995
4. Golab J. Interleukin 18-interferon gamma inducing factor-a novel player in tumour immunotherapy? Cytokine 2000; 12: 332-338
5. Iwasaki T, Yamashita K, Tsujimura T et al. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice. J Immunother 2002; Suppl 1: S52-60. doi:10 .1097/00002371-200203001-00008 PMid:12048351
6. Pagès F, Berger A, Henglein B et al. Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J cancer 1999; 84: 326-330 (Pubitemid 29256763)
7. Okano F, Yamada K. Canine interleukin-18 induces apoptosis and enhances Fas ligand mrNA expression in a canine carcinoma cell line. Anticancer Res 2000; 20: 3411-3415
8. Park CC, Morel JC, Amin MA et al. Evidence of IL-18 as a novel angiogenic Mediator. J Immunol 2001; 167: 1644-1653
9. Vidal-Vanaclocha F, Mendoza L, Telleria N et al. Clinical and experimental approaches to the pathophysiology of interleukin- 18 in cancer progression. Cancer Metastasis Rev. 2006; 25: 417-434 doi:10.1007/s10555-006- 9013-3 PMid:17001512 (Pubitemid 44922359)
10. Gunel N, Coskun U, Sancak B et al. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer 2002; 95: 663-667 doi:10.1002/ cncr.10705 PMid:12209760 (Pubitemid 34810193)
11. Sözen S, Coskun U, Sancak B et al. Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade. Neoplasma. 2004; 51: 25-29 (Pubitemid 38250153)
12. Giedraitis V, He B, Huang WX et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152 doi:10.1016/s0165-5728(00)00407-0 pmid:11108943
13. Mojtahedi Z, Naeimi S, Farjadian S et al. association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med 2006; 23: 235-239 doi:10.1111/j.1464- 5491.2006.01786.x PMid:16492204
14. Stassen NA, Breit CM, Norfleet LA et al. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 2003; 134: 351-356 doi:10.1067/msy.2003.248 PMid:12947340
15. Bushley AW, Ferrell R, Mcduffie K et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004; 95: 672-679 doi:10.1016/j.ygyno.2004.08.024 PMid:15581980 (Pubitemid 39592536)
16. Pratesi C, Bortolin MT, Bidoli E et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2006; 55: 23-30. doi:10.1007/s00262-005-0688-z (Pubitemid 41783289)
17. Wei YS, Lan Y, Liu YG et al. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 2007; 46: 1090-1096 doi:10.1080/02841860701373595 PMid:17851835 (Pubitemid 350058881)
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215. doi:10.1093/nar/16.3.1215 PMid:3344216 PMcid:334765
19. Naeimi S, Ghiam AF, Mojtahedi Z et al. Interleukin-18 gene promoter polymorphisms and recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2006; 128: 5-9. doi:10.1016/j.ejogrb.2006.02.012
20. Greten FR, Eckmann L, Greten TF et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296 doi:10.1016/j. cell.2004.07.013 PMid:15294155 (Pubitemid 39061110)
21. Aggarwal BB, Shishodia S, Sandur SK et al. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 2006; 72: 1605-1621 doi:10.1016/j.bcp.2006. 06.029 PMid:16889756 (Pubitemid 44666739)